Laurie Barclay, MD Oct. 14, 2002
Measuring nuchal translucency in the early second trimester may be the best single test for fetal trisomy 21 and other chromosomal abnormalities, according to a report in the October issue of Obstetrics & Gynecology.
“Increased fetal nuchal translucency seems to be a well-established ultrasonographic marker for fetal aneuploidy screening,” write Carmina Comas, PhD, and colleagues from the Institut Universitari Dexeus in Barcelona, Spain.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!